Bedmutha Indus. (BEDMUTHA)

Cyclical

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹113.63
Market Cap₹366.61 Cr
P/E Ratio56.53
ROCE16.67%
ROE4.38%
Dividend Yield0%
Profit Growth307.72%
Debt/Equity1.37
Sales Growth74.91%
Free Cash Flow₹-10,55,053.76 Cr
Promoter Holding57.05%
52-Week Range₹94.55 — ₹150.01
SectorIndustrial Products
Book Value₹47.09

Strengths

Concerns

AI Analysis

When I look at Bedmutha, I see a business fighting a difficult battle in a capital-intensive, cyclical industry. Iron and steel products have never been a breeding ground for durable moats; price takers, commodity inputs, and heavy fixed costs dominate. The numbers confirm my unease. Despite a 30% jump in sales, the latest quarter shows a net loss of ₹4 crore, and profit growth of -284% signals the erosion isn't an accident. Return on equity is negative at -4.25%, so shareholders' book value is being burned. Book value per share is ₹43.99, yet the market pays ₹116.90—a P/B of 2.66. For a money-losing steel company, that's optimism I can't stomach. Debt-to-equity of 1.52 amplifies the risk: in a downturn, fixed obligations become a noose. Free cash flow is deeply negative, meaning the reported sales growth may be bought with borrowing, not generated by operations. The Piotroski F-score of 4 out of 9 tells me financial health is weak, and with zero dividend, I get no income while waiting for a turnaround. To be fair, ROCE of 16.67% suggests some operating discipline, and promoter holding of 57% aligns owners with minority shareholders. But in Graham's terms, this is not an investment; it's speculation on a cyclical recovery. I'd need a margin of safety—a price well below book value, a cleaner balance sheet, and proof of consistent profitability. Until then, I'll watch from the sidelines.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer